logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
mobile logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
July 22, 2021
Uncategorized

輝瑞疫苗有效性高達90% 歐美股市大漲

輝瑞公司週一(9日)表示,大型研究結果顯示,輝瑞研製的新冠疫苗阻止了90%的新冠感染。這一效果比預期要好得多。消息公佈後,歐美市場狂歡,原油期貨價格也大幅度上漲。

輝瑞疫苗初步分析研究了43,000多名志願者中最先確診新冠的94例病例,這些病例分為兩組,一組接受了兩劑疫苗注射,一組接受了安慰劑。研究發現,只有不到10%的感染者是接種過疫苗的人。超過90%的病例發生在服用安慰劑的患者身上。

輝瑞公司說,疫苗在第二次接種後7天和第一次接種後28天提供保護。輝瑞製藥宣布,與德國生物科技公司BioNTech希望在今年年底前生產5000萬劑新冠疫苗,並計劃向食品和藥物管理局(FDA)尋求緊急使用許可。消息公佈後,歐美股市今早大幅攀升,歐洲股市普遍上漲6%以上,道瓊斯指數開盤大漲1500點,漲幅達5.3%,突破了道指過去的盤中最高點位記錄。

總統特朗普和當選總統拜登相繼表態。特朗普發推文稱,「股市大漲,疫苗即將上市,報告90%有效。這是很好的消息!」拜登隨後也發聲明表示,輝瑞的新冠疫苗進展是極好的消息,但距離在美國進行大規模接種還需要數月。

分享:

SHARE THIS ARTICLE

by admin
0
0
Previous post 美10月非農就業人數增加63.8萬人
Next post 洛克菲勒中心溜冰場11月21日開放 提前關閉

即時新聞

聯邦政府停擺兩週 白宮警告將繼續裁員

October 14, 2025

國防部公佈新新聞政策 多個新聞機構大力反對

October 14, 2025

勞資雙方未達協議 百老匯劇院或陷入停擺

October 14, 2025

布碌崙11歲男孩被車撞倒致傷 司機肇事逃逸

October 14, 2025

調查:美小企業樂觀情緒降至3個月低點

October 14, 2025
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Advertisement

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

Others

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

SAVE & ACCEPT

Terms and Conditions - Privacy Policy